
Sanofi CEO Sets Sights on Deals to Drive Turnaround
Reporting on market developments concerning Sanofi CEO Sets Sights on Deals to Drive Turnaround. Industry analysts and investors are monitoring the operational, strategic, and fina...
Query our full-text historical index across market dispatches, earnings reports, central bank policies, and financial analyses.

Reporting on market developments concerning Sanofi CEO Sets Sights on Deals to Drive Turnaround. Industry analysts and investors are monitoring the operational, strategic, and fina...

Alphabet has lost approximately $500 billion in market value as Wall Street scrutinizes mounting artificial intelligence expenditures and escalating antitrust headwinds.

A dramatic five-day crisis has sent shockwaves through the corporate legal sector, testing institutional governance and partner stability across top-tier advisory firms.

Thrive Capital has agreed to acquire smart home and security giant ADT in a $7.6 billion transaction, signaling an aggressive push into tech-enabled residential services.

A deep dive into how mid-market sports franchises utilize aggressive asset management and calculated trade risk to outmaneuver high-payroll rivals and expand enterprise value.

New York Knicks guard Josh Hart has returned his South Florida residence to the market at $5.699 million, reflecting broader price recalibration across prime luxury enclaves.

Ultra-wealthy buyers are pouring record sums into contiguous parcel assemblages, driving valuations past $300 million to build unprecedented mega-estates.

Advisory retention filings spotlight Character Technologies' operational positioning amid intense talent competition and shifting commercialization dynamics in generative AI.

Brinker International raised its annual profit and revenue guidance on Wednesday, powered by strong customer traffic and margin expansion at Chili's Grill & Bar.

Kylian Mbappé moves quickly to defuse a social media controversy in China, highlighting the delicate balance athletes and sponsors face in the world's second-largest economy.

GSK projects its oncology pipeline will nearly double next year, riding a wave of targeted acquisitions aimed at countering upcoming patent expirations.

As legacy publishers grapple with platform volatility and shifting digital ad revenue, The New York Times Co.'s multi-product subscription model continues to set the benchmark for media monetization.